Sangang B. Wu
Xiamen Key Laboratory Of Radiation Oncology
Xiamen, 361005, China
Xiamen, 361005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Real-World Treatment Practice and Survival Outcomes in Elderly Patients With Nasopharyngeal Carcinoma.
Journal: British journal of hospital medicine (London, England : 2005)
Published: November 02, 2025
Global research hotspots and trends of wildlife - associated zoonoses from 1990 to 2024
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: October 30, 2025
Association of lymph node ratio with adjuvant radiotherapy benefit in human papillomavirus-positive oropharyngeal squamous cell carcinoma: a population-based analysis.
Journal: Infectious agents and cancer
Published: August 03, 2025
Real-world treatment practices and survival outcomes of patients with de novo metastatic nasopharyngeal carcinoma after chemoimmunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: July 15, 2025
Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy.
Journal: Infectious agents and cancer
Published: June 18, 2025
Risk Stratification in T4 or N3 Nasopharyngeal Carcinoma.
Journal: Cancer research and treatment
Published: May 28, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinoma.
Journal: Cancer letters
Published: March 23, 2025
Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
Journal: BMC cancer
Published: February 07, 2025
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma.
Journal: Infectious agents and cancer
Published: February 05, 2025
A nomogram to predict the benefit of postmastectomy radiotherapy in breast cancer with nodal micrometastases.
Journal: Breast cancer (Tokyo, Japan)
Published: February 03, 2025
Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: November 20, 2024
Last Updated: 09/26/2026